Objective-To identify current screening and management practices for congenital dislocation of the hip (CDH), and determine the extent to which ultrasound imaging of the hips is practised throughout the United Kingdom and the Irish Republic. Methods-Postal questionnaire to paediatricians responsible for the routine neonatal care of infants in all maternity units in the UK and the Irish Republic.
A United Kingdom policy of universal screening for congenital dislocation of the hip (CDH) was other national screening programmes, an infrastructure is lacking to provide training in clinical examination and to define and monitor standards. However, such standards may be difficult to define as even experienced examiners may differ considerably in the criteria used to determine an acceptable OrtolaniBarlow test,12 or in its interpretation.34
The timing, nature, and duration of treatment of infants with hip instability varies widely in the United Kingdom. There have been no randomised trials of different treatment regimens, although the effectiveness of early non-surgical treatment is central to the rationale for screening. While only a small proportion of infants initially treated with a splint appliance appear to require subsequent surgery,20 recent data from two centres in the in the United Kingdom suggest that almost half of those requiring surgery for CDH are failures of early non-surgical treatment rather than failures of detection.4 8 The proportion of infants eventually treated is strongly influenced by the age at which diagnosis is confirmed and treatment started, as hip instability, when detected within the first days of life, usually resolves spontaneously.3537
The failure to implement current recommendations2 for keeping the hip screening programme under review was documented previously by Jones et al in 1991,38 and the findings of this survey suggest little improvement since then. This may reflect uncertainty as to how outcome should be assessed and the value of monitoring the programme within districts, where small numbers may preclude meaningful interpretation. An infrastructure to support a national audit is lacking. [39] [40] [41] The need for a formal evaluation of the costeffectiveness of both current and alternative methods of screening for GDH is increasingiy recognised.6 20 42 The emergence of hip ultrasound has renewed the impetus to evaluate current practices. In the United Kingdom, ultrasound is principally used as a secondary screening test and, although widespread, an opportunity to evaluate this practice remains. In January 1994, recruitment started to a MRC funded multicentre randomised trial to assess the cost-effectiveness of ultrasound in the management of infants with clinically detected hip instability. It is being coordinated by the Perinatal Trials Service in Oxford.
NWhile evaluation of primary screening for CDH should ideally include assessment of current, as well as alternative, screening methods, screening by the Ortolani-Barlow test has formed an established part of paediatric practice for more than a quarter of a century. This may have implications for the feasibility, acceptability, and medico-legal aspects of a trial of primary screening. Whatever the shape of future screening services, outcome measures and information systems are required to support routine monitoring of CDH. The challenge remains to develop a more scientific basis for screening services aimed at improving the outcome of this important and disabling childhood condition.
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